IRA Reality Check: Adapting Hub and Copay Programs to Ensure Patient Access and Affordability

In his more than 25-year career, Chris has become a recognized voice in the patient affordability and specialty medication arena, pioneering prominent copay and patient affordability programs, and creating innovative solutions for his clients.

Bill Sarraille is the founder of Sarraille & Associates, a life sciences regulatory consultancy. S&A works with patient groups and rare disease manufacturers on coverage, reimbursement, cost sharing, and access issues.

In addition, Bill is a policy adviser to the HIV and Hepatitis and Policy Institute and to FSHD Society, the patient group focused on a muscular dystrophy which has affected Bill and 5 generations of his family.  He also is a compliance adviser to Accessia Health, which is a 501(c)(3) that assists patients with cost sharing needs. Further, Bill is the General Counsel of the Pharmaceutical Coalition for Patient Access, which is a charitable organization dedicated to launching a mechanism to assist Medicare patients battling cancer. Bill is on the board of directors for both the FSHD Society and Kalderos, a health IT firm.

Finally, Bill is an Adjunct Professor at the University of Maryland Francis King Carey School of Law where he teaches pharmaceutical law.

Bill practiced health care law for 34 years, many of those years at Sidney Austin, where he was a Senior Partner in the Health Care and Life Sciences Practices, before his retirement in January.  During his law practice, Bill represented ConnectiveRx.